Phio Pharmaceuticals PHIO
NASDAQ PHIO
$1.21 +0.06 (+5.22%)
At close: Aug 20, 2026 · 4:00 PM EDT

Phio Pharmaceuticals (PHIO) Tax Provisions (2017)

Phio Pharmaceuticals' (PHIO) quarterly Tax Provisions came in at $1.6 million in Q4 2017, up 200.0% on a QoQ basis from -$1.6 million in Q1 2017.

Phio Pharmaceuticals (PHIO) Tax Provisions (2017) Analysis & Trends

Phio Pharmaceuticals (PHIO) has 1 years of Tax Provisions data on file, last reported at $1.6 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 59.00 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 15.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 75.45 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 13.31 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 1.90 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -90.33 Mn
10 Phio Pharmaceuticals 14.06 Mn 14.06 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 1.62 Mn
Mar 31, 2017 -1.62 Mn